Search results for: Innovation Policy Prize
Filter search results
Augmenting Cost-Effectiveness Analysis for Uncertainty: The Implications for Value Assessment—Rationale and Empirical Support
14 April 2020
…the reward-for-value equation, provide more consistent signals and thus the incentive to invest in more valuable innovations and in better healthcare. This study received unrestricted funding from the Pharmaceutical Research…
How Should the World Pay for a COVID-19 Vaccine?
31 July 2020
This year’s OHE lecture addressed the question: how should the world pay for a COVID-19 vaccine? The paper by Adrian Towse and Isobel Firth accompanying the lecture is now published….
The Value of Diagnostic information (VODI) in Heart Failure – Recognising Value Beyond ‘Beats-Per-Minute’
3 December 2020
…Heart Failure Policy Network, followed by presentations from Ms Sophie Marie Meiser, Manager of Market Access and Economic Policies at MedTech Europe, and Bernarda Zamora, Senior Economist at the Office…
Bridging the Gap: Pathways for Regulatory and Health Technology Assessment of Histology Independent Cancer Treatments
8 January 2021
Histology independent therapies are changing the picture of cancer treatment and in so doing don’t ‘fit the frame’ of value assessment. What are the key challenges on the pathway from…
The Influence of Cost-effectiveness and Other Factors on NICE Decisions
1 November 2013
…has said do influence its decisions would be difficult to measure for the purposes of this research — e.g. disease severity and “innovation”. Also not included were measures of the…
NGS testing for lung cancer across Europe still limited, despite clear case for adoption
10 July 2023
Wealth of evidence for clinical value and cost-saving potential of next-generation sequencing (NGS) testing in lung cancer now available Increased uptake requires focus on reimbursement, national standardisation, and new infrastructure…
Assessment of the Impact of Orphan Medicinal Products on the European Economy and Society
1 November 2010
…important — including, for example, improvements in treatment that positively affect the lives of both patient and caregiver and the development of research networks that create synergies, potentially accelerating innovation….
Sources of Information for Prescribing Doctors in Britain
9 January 1977
…The importance of this free flow of information for all concerned must be properly understood if pharmaceutical innovation and therapeutic progress is to prosper. This paper is intended as a…
Huntington’s Chorea
1 March 1980
…this disease by prenatal diagnosis and the abortion of ‘at risk’ foetuses will be introduced will depend on the social and economic restraints placed on this area of potential innovation….